MYOTONIC DYSTROPHY TYPE 2
Clinical trials for MYOTONIC DYSTROPHY TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DYSTROPHY TYPE 2 trials appear
Sign up with your email to follow new studies for MYOTONIC DYSTROPHY TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for myotonic dystrophy: new drug shows promise in easing muscle stiffness Long-Term
Symptom relief ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effectiveness of a drug called mexiletine PR for people with myotonic dystrophy types 1 and 2. The drug is taken once daily as a liquid to help reduce muscle stiffness (myotonia). The study includes 176 adults and teens who have alre…
Matched conditions: MYOTONIC DYSTROPHY TYPE 2
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Brain scans aim to unlock mysteries of muscle disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how myotonic dystrophy types 1 and 2 affect the brain. About 100 adults aged 30-65 will have MRI scans, thinking and movement tests, and blood draws. Some will also have a spinal tap. The goal is to find brain changes that could be used as markers in future tr…
Matched conditions: MYOTONIC DYSTROPHY TYPE 2
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC